Free Trial
→ I warned you about Nvidia… now look what’s happening (From Timothy Sykes) (Ad) Free NBIX Stock Alerts

Neurocrine Biosciences (NBIX) SEC Filings & 10K Form

Neurocrine Biosciences logo
$132.02 -2.09 (-1.56%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$131.99 -0.03 (-0.03%)
As of 07/18/2025 05:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Neurocrine Biosciences SEC Filings

Export to Excel
DateFilerForm TypeView
07/11/2025
4:15 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
4:01 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2025
3:32 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2025
3:10 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
4:34 PM		Keswani Sanjay Chandru (Reporting)
Neurocrine Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2025
4:37 PM		Keswani Sanjay Chandru (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
5:15 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
5:15 PM		Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:26 PM		Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:28 PM		Neurocrine Biosciences (Issuer)
Sharp Shalini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:29 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:32 PM		Neurocrine Biosciences (Issuer)
POON CHRISTINE A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:12 PM		Mercier Johanna (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:14 PM		Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:18 PM		LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:20 PM		MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
4:23 PM		Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
4:14 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:16 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:18 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:19 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:20 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:22 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:23 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:24 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:25 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:26 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:27 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
4:28 PM		Neurocrine Biosciences (Filer)
Form S-8 POS
05/21/2025
3:15 PM		Neurocrine Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/20/2025
3:43 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2025
6:05 PM		Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:40 PM		Neurocrine Biosciences (Subject)
RASTETTER WILLIAM H (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/28/2025
6:42 AM		BlackRock, Inc. (Filed by)
Neurocrine Biosciences (Subject)
Form SCHEDULE 13G/A
04/09/2025
3:04 PM		Neurocrine Biosciences (Filer)
Form DEF 14A
04/09/2025
3:06 PM		Neurocrine Biosciences (Filer)
Form DEFA14A
04/04/2025
7:02 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
1:09 PM		Neurocrine Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
6:13 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:49 PM		Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:57 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Critical AI announcement set to ignite AI 2.0 (Ad)

I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
02/14/2025
5:35 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:42 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:13 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:20 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:26 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:00 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:03 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:08 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:33 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:33 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:33 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM		Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:38 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:38 PM		Neurocrine Biosciences (Subject)
SHERWIN STEPHEN A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
5:41 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:44 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:46 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:48 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:49 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:52 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:56 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
6:00 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
3:51 PM		Neurocrine Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2025
3:04 PM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
5:50 AM		Neurocrine Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
02/04/2025
5:05 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:42 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:45 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:47 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:49 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:51 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:54 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:58 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:31 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:35 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:19 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:32 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
This Could Be the Most Profitable Season of Your Life (Ad)

Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.

Join The Crypto Code Workshop + get $10 in Bitcoin for attending
01/31/2025
3:32 PM		Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:33 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:34 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:29 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:27 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:29 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NBIX) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...
Timothy Sykes | Sponsored